Oregon Public Employees Retirement Fund Novavax Inc Transaction History

Oregon Public Employees Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$36.28 - $75.29 $293,033 - $608,117	-8,077 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$69.73 - $142.9 $62,757 - $128,610	-900 Reduced 10.03%	8,077 $595,000
Q4 2021 Feb 01, 2022	SELL	$134.56 - $217.97 $2.15 Million - $3.49 Million	-16,007 Reduced 64.07%	8,977 $1.28 Million
Q3 2021 Oct 19, 2021	BUY	$177.8 - $270.58 $345,643 - $526,007	1,944 Added 8.44%	24,984 $5.18 Million
Q2 2021 Jul 23, 2021	BUY	$121.0 - $257.67 $2.79 Million - $5.94 Million	23,040 New	23,040 $4.89 Million

241

76.1M

5.06M

7.19M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $990M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.